As South Korea continues its rise as a global hub for antibody–drug conjugate (ADC) innovation, the 5th World ADC South Korea Summit 2026 takes a uniquely Korean approach to agenda design. This year’s program is consciously inspired by Obangsaek (오방색), Korea’s traditional philosophy of five colors, using it as a conceptual lens to shape scientific discussion, collaboration, and strategic direction.
What Is Obangsaek & Why It Matters for ADCs
Obangsaek, translated as “five directional colors,” refers to the traditional Korean color system of blue (east), red (south), yellow (center), white (west), and black (north). Each color corresponds not only to a direction, but also to an element, season, and principle within East Asian philosophy, symbolizing balance between diverse forces rather than dominance of one.
In Korean culture, Obangsaek is used to organize everything from architecture and clothing to food and ritual. Applying this philosophy, this exclusive scientific summit reflects how breakthrough innovation emerges when multiple perspectives are intentionally balanced.
- Innovation & Growth (Blue / East)
Showcased by sessions on novel ADC formats, including dual‑payload ADCs and degrader antibody conjugates, representing forward‑looking growth and exploration. - Energy & Acceleration (Red / South)
Participate in clinical translation, first‑in‑human data, and late‑stage development discussions reflecting the momentum in the ADC field. - Stability & Integration (Yellow / Center)
Sessions on CMC, manufacturing efficiency, and regulatory alignment sit at the core of the agenda, acting as the stabilizing “center” that allows innovation to scale responsibly. - Purity & Rigor (White / West)
Explore talks on biomarker selection, pharmacokinetics, and data‑driven decision‑making sessions, which emphasize clarity and precision while developing the next generation of ADCs. - Depth & Strategic Wisdom (Black / North)
Engage in panel discussions with Korean and global leaders looking into long‑term differentiation strategies.